[go: up one dir, main page]

AR022578A1 - Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial - Google Patents

Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial

Info

Publication number
AR022578A1
AR022578A1 ARP000100605A ARP000100605A AR022578A1 AR 022578 A1 AR022578 A1 AR 022578A1 AR P000100605 A ARP000100605 A AR P000100605A AR P000100605 A ARP000100605 A AR P000100605A AR 022578 A1 AR022578 A1 AR 022578A1
Authority
AR
Argentina
Prior art keywords
artificial
preparation
surface activity
tensioactive
same
Prior art date
Application number
ARP000100605A
Other languages
English (en)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of AR022578A1 publication Critical patent/AR022578A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen péptidos artificiales análogos de la SP-C que tienen actividad superficial, y su uso para la preparacion de tensioactivos artificiales utilespara el tratamiento del síndrome de dificultad respiratoria (RDS) y otras enfermedades relacionadas a deficiencia o disfuncion de tensioactivo.
ARP000100605A 1999-02-12 2000-02-11 Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial AR022578A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Publications (1)

Publication Number Publication Date
AR022578A1 true AR022578A1 (es) 2002-09-04

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100605A AR022578A1 (es) 1999-02-12 2000-02-11 Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial

Country Status (32)

Country Link
US (1) US7053044B1 (es)
EP (1) EP1151008B1 (es)
JP (1) JP4754073B2 (es)
KR (1) KR100645145B1 (es)
CN (1) CN1221570C (es)
AR (1) AR022578A1 (es)
AT (1) ATE280181T1 (es)
AU (1) AU758735B2 (es)
BG (1) BG65196B1 (es)
BR (1) BR0009964A (es)
CA (1) CA2362507C (es)
CO (1) CO5241361A1 (es)
CZ (1) CZ301108B6 (es)
DE (1) DE60015082T2 (es)
EA (1) EA004058B1 (es)
EE (1) EE04879B1 (es)
ES (1) ES2228473T3 (es)
GE (1) GEP20032976B (es)
HU (1) HU228997B1 (es)
IL (1) IL144842A0 (es)
IT (1) IT1308180B1 (es)
MA (1) MA25381A1 (es)
NO (1) NO20013888D0 (es)
NZ (1) NZ513451A (es)
PL (1) PL201084B1 (es)
PT (1) PT1151008E (es)
SK (1) SK286428B6 (es)
TR (1) TR200102308T2 (es)
UA (1) UA72751C2 (es)
WO (1) WO2000047623A1 (es)
YU (1) YU57701A (es)
ZA (1) ZA200106530B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
JP2003522138A (ja) * 2000-02-11 2003-07-22 アルタナ ファルマ アクチエンゲゼルシャフト 慢性肺疾患の予防および治療のための肺表面活性剤の新規使用
ATE349223T1 (de) * 2002-03-01 2007-01-15 Chiesi Farma Spa Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN100401896C (zh) * 2002-12-09 2008-07-16 儿童医院医疗中心 诊断和治疗间质性肺病的方法
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
US20090011978A1 (en) * 2003-08-28 2009-01-08 Atlanta Pharma Ag Use of Surfactant Preparations for the Treatment of Surgical Adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
MX343064B (es) * 2006-10-13 2016-10-24 Chiesi Farm Spa Tensioactivos reconstituidos que tienen propiedades mejoradas.
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
TW201035111A (en) 2008-12-23 2010-10-01 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
WO2011029525A1 (en) 2009-09-08 2011-03-17 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
BR112014026212A8 (pt) * 2012-04-23 2019-12-24 Chiesi Farm Spa equipamento para administração de medicamento, processo para administração de um medicamento e uso de um equipamento para administração de medicamento
KR102122088B1 (ko) 2012-11-21 2020-06-12 키에시 파르마슈티시 엣스. 피. 에이. 재구성된 폐 계면활성제
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
HK1247140A1 (zh) 2015-04-22 2018-09-21 奇斯药制品公司 用於药物有效地呼吸同步递送到肺部的方法和系统
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
WO2016174269A1 (en) 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
CN109890446B (zh) 2016-10-26 2022-03-22 奇斯药制品公司 用于帮助通过导管向肺给送药剂的装置
CA3043792A1 (en) 2016-12-22 2018-06-28 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving bpd
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
JP7378425B2 (ja) 2018-04-23 2023-11-13 シエシー ファルマセウティチィ ソシエタ ペル アチオニ 肺サーファクタントおよびｂｐｄの予防のためのステロイドを含む治療的組合せ
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system
EP4464354A1 (en) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Method of operating an inhalation device, inhalation device and inhalation device system for providing inhalation process/breath guiding
EP4464236A1 (en) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Method of operating an inhalation device, inhalation device and inhalation device system for providing inhalation process feedback

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
KR100342806B1 (ko) * 1993-12-08 2002-11-29 미쯔비시 도꾜 세이야꾸 가부시끼가이샤 신규합성펩티드,이를함유하는폐표면활성제및호흡장애증후군치료제
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
CZ301108B6 (cs) 2009-11-11
YU57701A (sh) 2003-07-07
DE60015082D1 (de) 2004-11-25
CA2362507C (en) 2012-01-03
HU228997B1 (en) 2013-07-29
CN1340060A (zh) 2002-03-13
BG65196B1 (bg) 2007-06-29
UA72751C2 (en) 2005-04-15
WO2000047623A1 (en) 2000-08-17
EP1151008B1 (en) 2004-10-20
AU758735B2 (en) 2003-03-27
HUP0200141A3 (en) 2002-09-30
NO20013888L (no) 2001-08-09
KR100645145B1 (ko) 2006-11-10
JP4754073B2 (ja) 2011-08-24
PL349785A1 (en) 2002-09-09
ITMI990275A1 (it) 2000-08-12
BG105764A (en) 2002-03-29
SK286428B6 (sk) 2008-09-05
EA004058B1 (ru) 2003-12-25
NZ513451A (en) 2003-05-30
EP1151008A1 (en) 2001-11-07
NO20013888D0 (no) 2001-08-09
MA25381A1 (fr) 2002-04-01
EE200100413A (et) 2002-12-16
JP2002541062A (ja) 2002-12-03
HUP0200141A2 (en) 2002-06-29
CO5241361A1 (es) 2003-01-31
PT1151008E (pt) 2005-01-31
BR0009964A (pt) 2002-04-09
ZA200106530B (en) 2002-10-14
HK1042500A1 (en) 2002-08-16
EE04879B1 (et) 2007-08-15
US7053044B1 (en) 2006-05-30
SK11442001A3 (sk) 2001-12-03
PL201084B1 (pl) 2009-03-31
IT1308180B1 (it) 2001-12-07
CN1221570C (zh) 2005-10-05
IL144842A0 (en) 2002-06-30
ATE280181T1 (de) 2004-11-15
AU3279300A (en) 2000-08-29
GEP20032976B (en) 2003-05-27
CZ20012876A3 (cs) 2002-06-12
EA200100749A1 (ru) 2002-02-28
TR200102308T2 (tr) 2002-04-22
ES2228473T3 (es) 2005-04-16
DE60015082T2 (de) 2006-02-09
KR20010101904A (ko) 2001-11-15
CA2362507A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
AR022578A1 (es) Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial
ES2071306T3 (es) El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
ES2153820T3 (es) Derivados de benzimidazol, procedimiento para su preparacion y aplicaciones.
PE20000721A1 (es) Articulo absorbente que incluye un agente modificador de heces basado en calcio
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
PE20080339A1 (es) Polipeptidos del factor de coagulacion ix modificados y uso de los mismos para tratamiento
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
CO5060495A1 (es) Articulo limpiador y acondicionador para la piel o pelo desechable y substancialmente seco que tiene suministro de fragancia mejorado y metodo para su elaboracion
ES2186714T3 (es) Uso de sustipo simple alpha 8 en la preparacion de medicamentos para el tratamiento de infecciones virales del higado.
ATE333896T1 (de) Vaskularisierungsinhibitoren
UY26370A1 (es) "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación".
ES2103854T3 (es) Peptidos con actividad organo protectiva, procedimiento para la preparacion de los mismos y su utilizacion en la terapia.
ES2172680T3 (es) Ligante antagonista rar-gamma o agonista rar-alfa como inhibidor de apoptosis.
GT199900010A (es) Nuevas sulfonamidas naftil- y anilido-substituidas.
ES2148142T3 (es) Compuestos de 2-aril-5-(trifluorometil)-2-pirrolina y procedimiento para la fabricacion de insecticidas de 2-aril-1-(alcoximetil)-4-halo-5-(trifluorometil)pirrol.
ES2154311T3 (es) Quinoxalinas, procedimiento para su preparacion y su utilizacion.
ATE120207T1 (de) Zusammensetzung zur aktivierung der makrophagen.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ES2052484T1 (es) N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
UY27312A1 (es) Nuevos heterociclos 3
AR038642A1 (es) Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
ES2185310T3 (es) Agente antivirico herbario.
SE0000307D0 (sv) Method and formulation för treatment of vasoconstriction